Hoth Therapeutics Announces Acquisition of New Patent Applications
Hoth Therapeutics continues to invest in robust research and development strategies, ensuring the protection and growth of its proprietary technologies.
Biopharmaceutical Company | 22/01/2025 | By Aishwarya
CBC Group Acquires UCB's Mature Product Portfolio in China
The acquisition marks another successful transaction under CBC's buyout strategy of acquiring key assets from global pharmaceutical companies and a significant step in establishing a market-leading neurology company in China while expanding CBC's portfolio within the region's dynamic pharmaceutical market.
Biopharmaceutical Company | 03/12/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy